ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,168Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 324

$446K Total Retail Price of All Prescriptions

Rank: 126 out of 324

382 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 382 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,116 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 430 374 1 2
SIMVASTATIN 408 319 2 1
AMLODIPINE BESYLATE 348 326 3 4
LISINOPRIL 274 231 4 3
HYDROCODONE-ACETAMINOPHEN 267 193 S3 5 5
HYDROCHLOROTHIAZIDE 257 221 6 11
OMEPRAZOLE 240 175 7 6
ATORVASTATIN CALCIUM 224 177 8 12
FUROSEMIDE 221 171 9 7
PRAVASTATIN SODIUM 191 171 10 21
GABAPENTIN 165 126 11 13
POTASSIUM CHLORIDE 153 110 12 8
METFORMIN HCL 150 97 13 9
LOSARTAN POTASSIUM 142 120 14 15
NEXIUM 140 87 15 33
WARFARIN SODIUM 122 122 16 10
FLUTICASONE PROPIONATE 108 55 17 32
METOPROLOL TARTRATE 106 91 18 14
ZOLPIDEM TARTRATE 99 73 19 20
ATENOLOL 97 89 20 18
METOPROLOL SUCCINATE 96 86 21 17
CITALOPRAM HBR 94 78 22 16
CYMBALTA 84 39 23 45
ALENDRONATE SODIUM 83 83 24 24
TRAMADOL HCL 82 73 25 19
SERTRALINE HCL 80 60 26 23
DILTIAZEM 24HR ER 79 79 27 149
KLOR-CON M20 77 70 28 52
DIOVAN 71 57 29 56
CARVEDILOL 69 56 30 22
AZITHROMYCIN 68 60 31 48
ADVAIR DISKUS 67 47 32 61
OXYBUTYNIN CHLORIDE 64 61 33 88
LOSARTAN-HYDROCHLOROTHIAZIDE 59 47 34 44
CHLORTHALIDONE 58 58 35 230
BUMETANIDE 57 53 36 82
SYNTHROID 56 53 37 30
DIGOXIN 53 53 38 40
DILTIAZEM 24HR CD 52 49 39 81
HYDROMORPHONE HCL 52 0 S2 39 193
TERAZOSIN HCL 50 34 41 133
DONEPEZIL HCL 50 50 41 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.